[ Price : $8.95]
FDA approves Vertex Pharmaceuticals Kalydeco (ivacaftor) for use in certain children with cystic fibrosis ages four months to less...[ Price : $8.95]
FDA approves GlaxoSmithKlines Nucala (mepolizumab) for adults and children aged 12 years and older with hypereosinophilic syndrome...[ Price : $8.95]
FDA grants RemeGen a Breakthrough Therapy designation for disitamab vedotin (RC48), an anti-HER2 antibody drug conjugate for secon...[ Price : $8.95]
FDA publishes three guidances implementing the voluntary pilot for the Accreditation Scheme for Conformity Assessment.[ Price : $8.95]
The House Oversight and Reform Committee schedules two days of hearings on drug prices with testimony from executives of six compa...[ Price : $8.95]
Federal Register notice: FDA proposes to withdraw approval of five ANDAs because the application holders have repeatedly failed to...[ Price : $8.95]
After FDA commissioner Stephen Hahn assured Congress that FDAs review and approval/authorization of a Covid-19 vaccine would be ba...[ Price : $8.95]
FDA releases the FDA-483 with three observations from an inspection at Front Range Laboratories.